{"id":954785,"date":"2026-04-27T09:28:51","date_gmt":"2026-04-27T13:28:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/"},"modified":"2026-04-27T09:28:51","modified_gmt":"2026-04-27T13:28:51","slug":"centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/","title":{"rendered":"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model"},"content":{"rendered":"

<\/p>\n

CenterWell Pharmacy<\/b>\u00ae and <\/b>Mark Cuban Cost Plus Drug Company <\/b>Teaming up to Develop Disruptive Medication Model<\/b><\/p>\n

Collaboration focused on discounted prescription and direct delivery services<\/i><\/b><\/p>\n

LOUISVILLE, Ky. & DALLAS–(BUSINESS WIRE<\/a>)–CenterWell Pharmacy<\/a>\u00ae, a leader in specialty pharmacy and home delivery pharmacy and part of Humana Inc.<\/a> (NYSE:HUM), today announced a deepened partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs<\/a>) to develop new, end-to-end employer prescription solutions.<\/p>\n

\nAs part of this collaboration, Cost Plus Drugs has selected CenterWell Pharmacy\u00ae as a pharmacy partner. In addition, Cost Plus Drugs\u2019 digital pharmacy SaaS solution, SwiftyRx\u2122, will be used by CenterWell Pharmacy for its medication order intake operations.<\/p>\n

\nMore broadly, by combining SwiftyRx\u2019s innovative technology, Cost Plus Drugs\u2019 industry\u2011leading low prices, and CenterWell Pharmacy’s distribution capabilities, the organizations intend to partner on a new employer-based program design. The goal is to simplify medication access and lower patient cost by streamlining patient onboarding, automating benefit checks, reducing cost-to-fill, and driving greater operational efficiencies.<\/p>\n

\n\u201cEveryone should be able to get safe, affordable medication,\u201d said Mark Cuban, co-founder of Cost Plus Drugs. \u201cThis collaboration gives Cost Plus Drugs the chance to support more consumers. We\u2019re working with CenterWell Pharmacy because we trust the team and like what they\u2019re doing in trying to improve prescription affordability.\u201d<\/p>\n

\nThe SwiftyRx\u2122 platform is expected to enable CenterWell Pharmacy\u00ae to have the capability to offer home delivery pharmacy services to Humana\u2019s eligible workforce enrolled in the Humana Associate Benefit Plan.<\/p>\n

\n\u201cToday\u2019s announcements reflect an aligned mission to redesign access and affordability in a simplified approach, to help patients get the medications they need,\u201d said Bethanie Stein, Pharm.D., President, Pharmacy at Humana, including CenterWell Pharmacy\u00ae. \u201cCenterWell\u2019s value as a distribution partner lies in our capacity, infrastructure, and proven quality measures, all of which drive a better experience for our patients. That\u2019s important as we focus on greater medication adherence and patient health outcomes across the country.\u201d<\/p>\n

About Mark Cuban Cost Plus Drug Company<\/b><\/p>\n

\nThe Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) aims to fundamentally change the way the pharmaceutical industry operates. As a public-benefit corporation, its social mission of improving public health is just as important as the bottom line. Cost Plus Drugs transparently charges a standard markup on every drug it sells. The costplusdrugs.com<\/a> online pharmacy launched in January 2022 now carries over 2,300 prescription products, delivered by mail to thousands of happy customers every day. Customers can also go to participating retail pharmacies to receive Cost Plus Drugs pricing through the Team Cuban Card<\/a>. Cost Plus Drugs is working with health plans, managed-care organizations, PBMs, and self-insured employers to bring these same savings to benefit plans nationwide. Learn more at www.markcubancostplusdrugcompany.com<\/a>.<\/p>\n

About CenterWell\u00ae<\/b><\/p>\n

\nCenterWell\u00ae is a leading health care services business focused on creating integrated and differentiated experiences that put our patients at the center of everything we do. The result is high quality health care that is accessible, comprehensive, and, most of all, personalized. As the largest provider of senior-focused primary care, a leading provider of home health care, and a leading integrated home delivery, specialty, and retail pharmacy, CenterWell\u00ae is focused on whole health and addressing the physical, emotional and social wellness of our patients.<\/p>\n

\nCenterWell\u00ae is part of Humana Inc. (NYSE: HUM). Learn more about what we offer at CenterWell.com<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260427894411\/en\/<\/a><\/span><\/p>\n

\nAlissa Krinsky
\n
CenterWell Corporate Communications
\n
akrinsky@humana.com
\n<\/a><\/p>\n

Cost Plus Drugs
\n
press@costplusdrugs.com<\/a><\/p>\n

KEYWORDS:<\/b> Texas Kentucky United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> General Health Other Health Health Pharmaceutical Managed Care<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model Collaboration focused on discounted prescription and direct delivery services LOUISVILLE, Ky. & DALLAS–(BUSINESS WIRE)–CenterWell Pharmacy\u00ae, a leader in specialty pharmacy and home delivery pharmacy and part of Humana Inc. (NYSE:HUM), today announced a deepened partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to develop new, end-to-end employer prescription solutions. As part of this collaboration, Cost Plus Drugs has selected CenterWell Pharmacy\u00ae as a pharmacy partner. In addition, Cost Plus Drugs\u2019 digital pharmacy SaaS solution, SwiftyRx\u2122, will be used by CenterWell Pharmacy for its medication order intake operations. More broadly, by combining SwiftyRx\u2019s innovative technology, Cost Plus Drugs\u2019 industry\u2011leading low prices, and … <\/p>\n

Continue reading “CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-954785","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model Collaboration focused on discounted prescription and direct delivery services LOUISVILLE, Ky. & DALLAS–(BUSINESS WIRE)–CenterWell Pharmacy\u00ae, a leader in specialty pharmacy and home delivery pharmacy and part of Humana Inc. (NYSE:HUM), today announced a deepened partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to develop new, end-to-end employer prescription solutions. As part of this collaboration, Cost Plus Drugs has selected CenterWell Pharmacy\u00ae as a pharmacy partner. In addition, Cost Plus Drugs\u2019 digital pharmacy SaaS solution, SwiftyRx\u2122, will be used by CenterWell Pharmacy for its medication order intake operations. More broadly, by combining SwiftyRx\u2019s innovative technology, Cost Plus Drugs\u2019 industry\u2011leading low prices, and … Continue reading "CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-27T13:28:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model\",\"datePublished\":\"2026-04-27T13:28:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/\"},\"wordCount\":623,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/\",\"name\":\"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-04-27T13:28:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/","og_locale":"en_US","og_type":"article","og_title":"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model - Market Newsdesk","og_description":"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model Collaboration focused on discounted prescription and direct delivery services LOUISVILLE, Ky. & DALLAS–(BUSINESS WIRE)–CenterWell Pharmacy\u00ae, a leader in specialty pharmacy and home delivery pharmacy and part of Humana Inc. (NYSE:HUM), today announced a deepened partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to develop new, end-to-end employer prescription solutions. As part of this collaboration, Cost Plus Drugs has selected CenterWell Pharmacy\u00ae as a pharmacy partner. In addition, Cost Plus Drugs\u2019 digital pharmacy SaaS solution, SwiftyRx\u2122, will be used by CenterWell Pharmacy for its medication order intake operations. More broadly, by combining SwiftyRx\u2019s innovative technology, Cost Plus Drugs\u2019 industry\u2011leading low prices, and … Continue reading \"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-27T13:28:51+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model","datePublished":"2026-04-27T13:28:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/"},"wordCount":623,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/","name":"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-04-27T13:28:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260427894411r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/centerwell-pharmacy-and-mark-cuban-cost-plus-drug-company-teaming-up-to-develop-disruptive-medication-model\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CenterWell Pharmacy\u00ae and Mark Cuban Cost Plus Drug Company Teaming up to Develop Disruptive Medication Model"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=954785"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954785\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=954785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=954785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=954785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}